Blog Home

Advocacy

Childhood Cancer

Did You Know
Common Types

Dean’s Reflections

Fundraising & Events

Community Partners
September

Rally Stories

Kids
Teens
Families
Survivors

Research

Grant Awards
Rally Researchers
Success Stories

Rally Researchers

How Rally’s Grant Helped Rally Researcher Dr. Michael Kinnaman: Part 2

How Rally’s Grant Helped Rally Researcher Dr. Michael Kinnaman: Part 2

by | Apr 24, 2020

Rally Researcher, Medical Advisory Board member and pediatric oncologist Dr. Michael Kinnaman is the recipient of Rally’s Postdoctoral and Clinical Research Fellow Grant and most recently was awarded a 2020 Young Investigator Grant. In part two of this two-part series, Dr. Kinnaman reveals how our grant has helped fund his research project on characterizing osteosarcoma tumor cells that are resistant to our current therapy with the end goal of discovering new treatment strategies that are specifically targeted towards these resistant tumor cells. Read part one here.   Dr. Kinnaman Seeks to Understand the Complexities of Osteosarcoma One of the first patients I saw as a fellow at MSK Kids, Memorial Sloan Kettering’s Pediatric program, was a 12-year-old boy with newly diagnosed osteosarcoma of his right thigh bone. Osteosarcoma is the most common malignant bone tumor in children and...

read more
Why I Chose Pediatric Oncology and Research

Why I Chose Pediatric Oncology and Research

by | Apr 13, 2020

Rally Researcher and pediatric oncologist Dr. Michael Kinnaman received a Rally Postdoctoral and Clinical Research Fellow Grant. In part one of this two-part series, Dr. Kinnaman shares his story and why he was drawn to pediatric oncology and research. Have you ever wondered about the career path of a pediatric oncologist and clinical researcher? Dr. Kinnaman's journey began with a decision made during his sophomore year in college. Having dual passions for law and science, Dr. Kinnaman majored in both political science and biology. He had envisioned earning a law degree after graduation and working for a biotechnology or pharmaceutical company. However, this vision began to change after a foray into clinical research, as well as a brief hospital stay. The following is part one of our two-part blog series: Dr. Kinnaman Shares How He Discovered His Passion For Medicine My journey to...

read more

$3.3 Million of Good News

by | Apr 1, 2020

Could you use some good news? We have some good news. Actually, we have some GREAT news! Rally Foundation for Childhood Cancer Research just awarded $3.3 million in childhood cancer research grants. This is our largest single-year commitment and brings Rally Foundation’s awarded total to $20 million to find better treatments with fewer long-term side effects and, ultimately, cures. Thank you to our supporters who made these grants possible. Thank you to the Rally Medical Advisory Board who vetted close to 125 full applications. Thank you to our partners in the Collaborative Pediatric Cancer Research Awards Program (The Truth 365, Open Hands Overflowing Hearts, Infinite Love for Kids Fighting Cancer, Luke Tatsu Johnson Foundation, Batcole Foundation, Leukemia and Lymphoma Society and CureSearch for Children’s Cancer) who are like-minded foundations working together to co-fund projects...

read more
Newly Elected COG Chair Dr. Douglas Hawkins Shares His ‘North Star’

Newly Elected COG Chair Dr. Douglas Hawkins Shares His ‘North Star’

by | Mar 22, 2020

Rally was pleased when it was announced that the newly elected chair of the Children’s Oncology Group (COG) was going to be Dr. Doug Hawkins, a Rally-funded Researcher who has served for the past nine years on the Rally Medical Advisory Board and received funding for early phase trials and biologic specimen collection at Seattle Children’s Hospital (SCH). Dr. Hawkins is also the Division Chief of Hematology-Oncology and the Associate Director of the Center for Clinical and Translational Research at SCH. He transitioned into his role as chair this month, taking the reins from fellow Rally-funded Researcher, Medical Advisory Board member and current COG chair, Dr. Peter Adamson. At Rally, we work endlessly to uphold our mission of funding childhood cancer research in hopes of finding better treatments with fewer long-term side effects and ultimately, a cure. We believe that every child...

read more
Research for Recurrent Brain Tumors Shows Promising Preliminary Results

Research for Recurrent Brain Tumors Shows Promising Preliminary Results

by | May 9, 2019

As a Rally Researcher and the primary investigator at the University of Alabama at Birmingham, Gregory Friedman, M.D. is devoted to studying malignant brain tumors in hopes of developing new and improved immunotherapies to treat children with recurrent tumors. One such treatment has shown promising preliminary results, and the therapy involves an unexpected source: the common cold sore virus, otherwise known as herpes simplex or G207. Thanks to Rally Foundation funding, Dr. Friedman and his team were able to alter the virus to kill cancer cells, while also obtaining critical preclinical data needed to conduct a pediatric study. So far, out of seven children, the early results show the therapy to be safe, tolerable and promising. In order to gain a better understanding of his research and the clinical trials, we sat down with Dr. Friedman to find out the following: how pediatric...

read more

$

Sign up for our emails!

Fill out my online form.

Recent Posts

< Blog Home

Rally Researchers

How Rally’s Grant Helped Rally Researcher Dr. Michael Kinnaman: Part 2

How Rally’s Grant Helped Rally Researcher Dr. Michael Kinnaman: Part 2

by | Apr 24, 2020

Rally Researcher, Medical Advisory Board member and pediatric oncologist Dr. Michael Kinnaman is the recipient of Rally’s Postdoctoral and Clinical Research Fellow Grant and most recently was awarded a 2020 Young Investigator Grant. In part two of this two-part series, Dr. Kinnaman reveals how our grant has helped fund his research project on characterizing osteosarcoma tumor cells that are resistant to our current therapy with the end goal of discovering new treatment strategies that are...

read more
Why I Chose Pediatric Oncology and Research

Why I Chose Pediatric Oncology and Research

by | Apr 13, 2020

Rally Researcher and pediatric oncologist Dr. Michael Kinnaman received a Rally Postdoctoral and Clinical Research Fellow Grant. In part one of this two-part series, Dr. Kinnaman shares his story and why he was drawn to pediatric oncology and research. Have you ever wondered about the career path of a pediatric oncologist and clinical researcher? Dr. Kinnaman's journey began with a decision made during his sophomore year in college. Having dual passions for law and science, Dr. Kinnaman...

read more

$3.3 Million of Good News

by | Apr 1, 2020

Could you use some good news? We have some good news. Actually, we have some GREAT news! Rally Foundation for Childhood Cancer Research just awarded $3.3 million in childhood cancer research grants. This is our largest single-year commitment and brings Rally Foundation’s awarded total to $20 million to find better treatments with fewer long-term side effects and, ultimately, cures. Thank you to our supporters who made these grants possible. Thank you to the Rally Medical Advisory Board who...

read more
Newly Elected COG Chair Dr. Douglas Hawkins Shares His ‘North Star’

Newly Elected COG Chair Dr. Douglas Hawkins Shares His ‘North Star’

by | Mar 22, 2020

Rally was pleased when it was announced that the newly elected chair of the Children’s Oncology Group (COG) was going to be Dr. Doug Hawkins, a Rally-funded Researcher who has served for the past nine years on the Rally Medical Advisory Board and received funding for early phase trials and biologic specimen collection at Seattle Children’s Hospital (SCH). Dr. Hawkins is also the Division Chief of Hematology-Oncology and the Associate Director of the Center for Clinical and Translational...

read more
Research for Recurrent Brain Tumors Shows Promising Preliminary Results

Research for Recurrent Brain Tumors Shows Promising Preliminary Results

by | May 9, 2019

As a Rally Researcher and the primary investigator at the University of Alabama at Birmingham, Gregory Friedman, M.D. is devoted to studying malignant brain tumors in hopes of developing new and improved immunotherapies to treat children with recurrent tumors. One such treatment has shown promising preliminary results, and the therapy involves an unexpected source: the common cold sore virus, otherwise known as herpes simplex or G207. Thanks to Rally Foundation funding, Dr. Friedman and his...

read more

$

Sign up for our emails!

Fill out my online form.

Recent Posts

Volunteers are the heart of Rally's mission!

 

Enter your email below to receive details about our volunteer opportunities.

Thank you for your interest in volunteering with Rally! You should receive an email shortly with additional details.